FUSE GROUP HOLDING INC. (FUST): debt financing — Fuse Group Holding issues $30K convertible note to Chen Fei Li at $0.33 conversion

FUSE GROUP HOLDING INC.

Principal $30,000, 3% annual interest, payable May 1, 2026 and 2027.
Maturity 24 months from purchase price date; convertible at $0.33/share at holder's option.
Note sold under Regulation S exemption to non-U.S. person; funds for general corporate purposes.
Company reserves sufficient common shares for conversion; event of default has 90-day cure period for payment.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

FUSE GROUP HOLDING INC. incurred convertible notes of $30,000 with Chen Fei Li at 3% per annum maturing twenty-four months from the date that the purchase price of the Note is paid to the Company.

Instrument: convertible notes
Principal: $30,000
Counterparty: Chen Fei Li
Rate: 3% per annum
Maturity: twenty-four months from the date that the purchase price of the Note is paid to the Company
Event: incurrence

Exact text from the filing

On May 1, 2025, Fuse Group Holding Inc. (the “Company”), entered into a Convertible Promissory Note Purchase Agreement (the “Agreement”) with Chen Fei Li, a Chinese citizen (the “Purchaser”). Pursuant to the Agreement, the Company sold a Convertible Promissory Note to the Purchaser with a principal amount of $30,000 (the “Note”). The Note bears interest at the rate of 3% per annum, which are payable on May 1 of 2026 and 2027. The Note will mature on the date that is twenty-four months from the date that the purchase price of the Note is paid to the Company.

View on SEC.gov

Browse all debt financings →

FUSE GROUP HOLDING INC. filing history →

Source: SEC EDGAR

accession 0001185185-25-000393

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.